Photo from wikipedia
Key Points • GMP-based iPSC-platelet production using imMKCL master cells from an aplastic anemia patient with alloimmune transfusion refractoriness.• Extensive nonclinical evaluation confirmed the safety, quality, and efficacy of the… Click to show full abstract
Key Points • GMP-based iPSC-platelet production using imMKCL master cells from an aplastic anemia patient with alloimmune transfusion refractoriness.• Extensive nonclinical evaluation confirmed the safety, quality, and efficacy of the patient iPSC-platelet product.
Keywords:
nonclinical evaluation;
production nonclinical;
platelet product
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!